[1] Singh, Anubha, Tandon, et al. An update on vascular calcification and potential therapeutics.
[2] 陈荣,李怡,王莉.慢性肾脏病VC诊治进展[J].实用医院临床杂志,2022,19(02):183-186.
[3] Kerstin B , Karl-Friedrich H , Christoph D , et al. Vascular Calcification in Chronic Kidney Disease: The Role of Inflammation[J]. International Journal of Nephrology, 2018, 2018:1-7.
[4] Liu ZH, Yu XQ, Yang JW, et al. Prevalence and risk factors for vascularcalcification in Chinese patients receiving dialysis: baseline results from aprospective cohort study. Curr Med Res Opin, 2018, 34(8): 1491-1500
[5] Singh, Anubha, Tandon, et al. An update on vascular calcification and potential therapeutics.
[6] 马清华, 刘玉秀, 申红远,等. VC的调控因子[J]. 中华老年心脑血管病杂志, 2015.
[7] Shroff R , Long D A , Shanahan C . Mechanistic Insights into Vascular Calcification in CKD[J]. Journal of the American Society of Nephrology Jasn, 2013, 24(2):179-189.
[8] Vahed S Z , Mostafavi S , Khatibi S , et al. Vascular Calcification: An Important Understanding in Nephrology[J]. Vascular Health and Risk Management, 2020, Volume 16:167-180.
[9] Sun J L , Lee I K , Jeon J H . Vascular Calcification—New Insights into Its Mechanism[J]. International Journal of Molecular Sciences, 2020, 21(8).
[10] Himmelsbach A , Ciliox C , Goettsch C . Cardiovascular Calcification in Chronic Kidney Disease-Therapeutic Opportunities[J]. Toxins, 2020, 12(3).
[11] Waziri B, Duarte R, Naicker S. Chronic kidney disease–mineral and bone disorder (CKD-MBD): current perspectives[J]. International journal of nephrology and renovascular disease, 2019, 12: 263.
[12] 兰天鹰, 叶朝阳, 姚东升,等. 123例维持性血液透析患者矿物质及骨代谢水平的调查分析[J]. 临床肾脏病杂志, 2018, 18(8):5.
[13] Carrillo-López Natalia, Sara P , Cristina A M , et al. High-serum phosphate and parathyroid hormone distinctly regulate bone loss and vascular calcification in experimental chronic kidney disease[J]. Nephrology Dialysis Transplantation(6):6.
[14] Jeffrey W , Jimmy Z , Graham R , et al. Vitamin D in Vascular Calcification: A Double-Edged Sword?[J]. Nutrients, 2018, 10(5):652.
[15] Cui Q . Extra-Large Gα Protein (XLαs) Deficiency Causes Severe Adenine-Induced Renal Injury with Massive FGF23 Elevation[J]. Endocrinology, 2020, 161(1):pii: bqz025.
[16] 杨枫,林评兰,邹赟,等. Klotho在慢性肾脏病血管钙化中作用的研究进展[J]. 中国血液净化,2021,20(3):189-192. DOI:10.3969/j.issn.1671-4091.2021.03.010.
[17] Cianciolo G, Galassi A, Capelli I, et al. Klotho-FGF23, cardiovascular disease, and vascular calcification: black or white?[J]. Current vascular pharmacology, 2018, 16(2): 143-156.
[18] Ignacio C P ,Petra S . PTH, FGF-23, Klotho and Vitamin D as regulators of calcium and phosphorus: Genetics, epigenetics and beyond [J]. Frontiers in Endocrinology,2022,13.
[19] Kuro-o M. The Klotho proteins in health and disease[J]. Nature Reviews Nephrology, 2019, 15(1): 27-44.
[20] Carrillo-López N ,Martínez-Arias L ,Fernández-Villabrille S , et al. Role of the RANK/RANKL/OPG and Wnt/β-Catenin Systems in CKD Bone and Cardiovascular Disorders[J]. Calcified Tissue International,2021,108(4).
[21] Chen Y X, Huang C, Duan Z B, et al. Klotho/FGF23 axis mediates high phosphate‐induced vascular calcification in vascular smooth muscle cells via Wnt7b/β‐catenin pathway[J]. The Kaohsiung Journal of Medical Sciences, 2019, 35(7): 393-400.
[22] Wu Q, Fan W, Zhong X, et al. Klotho/FGF23 and Wnt in SHPT associated with CKD via regulating miR-29a[J]. American Journal of Translational Research, 2022, 14(2): 876.
[23] Komori T . What is the function of osteocalcin?[J]. Journal of Oral Biosciences, 2020, 62(3).
[24] Namba S , Yamaoka-Tojo M , Hashikata T , et al. Long-term warfarin therapy and biomarkers for osteoporosis and atherosclerosis[J]. BBA Clinical, 2015.
[25] Chi P J, Lin Y L, Tasi J P, et al. Osteocalcin and carotid–femoral pulse wave velocity in patients on peritoneal dialysis[J]. Tzu-Chi Medical Journal, 2019, 31(1): 23.
[26] Millar S A , Hinal P , Anderson S I , et al. Osteocalcin, Vascular Calcification, and Atherosclerosis: A Systematic Review and Meta-analysis[J]. Frontiers in Endocrinology, 2017, 8:183.
[27] Yeap B B , Chubb S , Flicker L , et al. Associations of total osteocalcin with all-cause and cardiovascular mortality in older men. The Health In Men Study[J]. Osteoporosis International, 2012.
[28] E, Lerchbaum, V, et al. Association of bone turnover markers with mortality in men referred to coronary angiography[J]. Osteoporosis International, 2013.
[29] Ning F L , Tao J , Li D D , et al. Activating BK channels ameliorates vascular smooth muscle calcification through Akt signaling[J]. Acta Pharmacologica Sinica.
[30] Luo F , Guo W , Liu W . Exosomes derived from bone marrow mesenchymal stem cells inhibit human aortic vascular smooth muscle cells calcification via the miR-15a/15b/16/NFATc3/OCN axis[J]. Biochemical and biophysical research communications, 2022, 635:65-76.
[31] Dai L , Debowska M , Lukaszuk T , et al. Phenotypic features of vascular calcification in chronic kidney disease[J]. Journal of Internal Medicine, 2020, 287.
[32] Yang Z K , Ying C , Zhao H Y , et al. Mineral metabolism disturbances are associated with the presence and severity of calcific aortic valve disease[J]. 浙江大学学报B辑(生物医学与生物技术)(英文版), 2015.
[33] Jasna A , Samantha K , Mirna V D , et al. Aortic vascular calcification is inversely associated with the trabecular bone score in patients receiving dialysis[J]. Bone, 2018, 113:118-123.
[34] Deluccia R , Cheung M , Ramadoss R , et al. The Endocrine Role of Bone in Cardiometabolic Health[J]. Current Nutrition Reports, 2019, 8(1).
[35] Cavalier E , Lukas P , Carlisi A , et al. Aminoterminal propeptide of type I procollagen (PINP) in chronic kidney disease patients: the assay matters.[J]. CLINICA CHIMICA ACTA, 2013.
[36] Diemar S S , Dahl S S , West A S , et al. A Systematic Review of the Circadian Rhythm of Bone Markers in Blood[J]. Calcified Tissue International, 2022:1-22.
